U.S. Markets close in 3 hrs 30 mins

Why new cancer trial data is good news for a Triangle pharma

Seth Thomas Gulledge
Why new cancer trial data is good news for a Triangle pharma

New clinical data out a recent cancer study spells good news for a Triangle drugmaker, as well as patients who could see longer lives thanks to its product.